Journal of Perinatal Medicine · 2014 · 14 citations · 6 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicineObstetric ComplicationsPreterm BirthPerinatal Risk FactorsPregnancyPrenatal AssessmentPrenatal Risk AssessmentPreterm Birth EpidemiologyScreening For Preterm BirthControl Group DesignMatched Control GroupObstetric Risk AssessmentPregnancy Loss RiskPregnancy Outcome AssessmentPreterm Birth Risk AnalysisPreterm Delivery Risk AssessmentProcedure-related Pregnancy Loss
OBJECTIVES: The purpose of this retrospective controlled study is to estimate the risk for fetal loss and preterm delivery attributed to second trimester amniocentesis from a single tertiary center. METHODS: The study group consists of 12,413 singleton pregnancies with consecutive amniocenteses, performed in a single tertiary center during a 15-year period (1996-2010) with known pregnancy outcome. The control group consisted of 6993 pregnancies with negative second trimester screening for aneuploidies during the same period who did not have any invasive test. The two groups were compared in terms of fetal loss rate up to 24 weeks and premature deliveries. RESULTS: Total fetal loss up to 24 weeks in the study group, excluding terminations of pregnancy, was estimated at 1.25% (1.05%-1.45%, confidence interval [CI]: 95%). In the control group the loss rate was 0.65% giving a procedure related fetal loss rate of 0.6% which was not found to be a statistically significant difference. Delivery before the 28th, 32nd, 34th, and 37th week in the study group was reported in 0.2%, 0.8%, 1.2% and 8.1% respectively, and it was not statistically different from controls. CONCLUSION: The present study has shown that the risk of miscarriage that can be attributed to amniocentesis in our institution is 0.6%, and this is not statistically significant when compared with cases without any invasive procedure during pregnancy. Similarly, the risk for preterm labor was not statistically significant when compared with controls.
6
RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN
Ann Tabor, Mette Madsen, Erikb. Obel et al. · The Lancet · 1986 · 873 citations
Medicine, Genetics, Obstetrics +8
Amniocentesis-Related Fetal Loss: A Cohort Study
Theera Tongsong · Obstetrics and Gynecology · 1998 · 64 citations
Genetic amniocentesis in women 20-34 years old: associated risks
Aris Antsaklis, Nikolaos Papantoniou, Antonios Xygakis et al. · Prenatal Diagnosis · 2000 · 56 citations